Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/2003
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003US20030130165 Method for treating neurodegenerative disorders
07/10/2003US20030129712 By reacting heterocyclic ketones with a cyanide donor in the presence of a hydroxynitrile lyase
07/10/2003CA2482392A1 Carboxylic acid derivative
07/10/2003CA2471236A1 Urea derivatives
07/10/2003CA2469967A1 Urea derivatives as vr1- antagonists
07/09/2003EP1325920A1 N-substituted benzothiophenesulfonamide derivatives
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1325744A1 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof
07/09/2003EP1325742A1 Improved transdermal therapeutic system for the treatment of Parkinson's disease
07/09/2003EP1325671A1 Organometallic compounds and emission-shifting organic electrophosphorescence
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP1324759A2 Nf-g(k)b inhibitors
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1429199A Insecticidal 1,8-naphthalenedicarboxamides
07/09/2003CN1429198A Novel phenyl-proparylether derivatives
07/09/2003CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor
07/09/2003CN1113890C Heterocyclic metallocenes and polymerization catalysts
07/09/2003CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/08/2003US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes)
07/08/2003US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits
07/08/2003US6590100 Reacting an aromatic compound bearing a leaving group and an arylboronic acid and/or its derivatives in the presence of a base and an effective amount of a nickel catalyst
07/08/2003US6589976 Particularly effective wood preservation is achieved by impregnation processes on a large industrial scale, for example vacuum, a double vacuum or pressure processes.
07/08/2003US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist.
07/08/2003US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production
07/08/2003CA2285208C Improved method for producing thiazolidinediones, and new thiazolidinediones
07/03/2003WO2003054053A1 New 3,4-alkylenedioxythiophene compounds and polymers thereof
07/03/2003WO2003053971A1 Pyridoquinoxaline antivirals
07/03/2003WO2003053954A1 Benzothiophenes as adenosine receptor modulators
07/03/2003WO2003053953A1 Thiophene derivatives and their use as fragrants
07/03/2003WO2003053944A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003WO2003053917A1 Guanidine compounds and pest controllers
07/03/2003WO2003053914A1 Novel amidine derivatives and the use of the same in pharmaceuticals
07/03/2003WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053359A2 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
07/03/2003US20030125590 For effecting reactions and/or separations using organic molecule, moiety or group having a domain or a portion thereof rich in carbon-fluorine bonds
07/03/2003US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them
07/03/2003US20030125383 For treating or preventing emphysema, cancer and dermatological disorders
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003CA2471089A1 Pyridoquinoxaline antivirals
07/03/2003CA2470931A1 Chalcone derivatives and their use to treat diseases
07/03/2003CA2469872A1 Benzothiophenes as adenosine receptor modulators
07/03/2003CA2469609A1 Thiophene derivatives and their use as fragrants
07/02/2003EP1323830A2 Process for the preparation of heterocyclic (R)- and (S)-cyanohydrines
07/02/2003EP1323724A2 Novel ruthenium complexes and process for preparing alcoholic compounds using these
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322633A2 Aryloxy ester and acid compounds
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322630A2 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
07/02/2003EP1322610A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
07/02/2003EP1322592A1 Substituted 1-aminobutan-3-ol derivatives
07/02/2003EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives
07/02/2003EP1322331A2 Fatty acid synthase inhibitors
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003EP0848700B1 Acylaminosalicylic acid amides and their uses as pesticides
07/01/2003US6586627 N-protected/N-substituted-beta-amino hydroxy sulfonates
07/01/2003US6586466 Carbohydrazide-protease inhibitors
07/01/2003US6586462 ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
07/01/2003US6586461 Geranylgeranyl transferase inhibitors comprising farnesol and geranylgeraniol analogs, used as anticarcinogenic agents and for prevention of restenosis
07/01/2003US6586459 Antithrombotic agents
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/28/2003CA2414265A1 Novel ruthenium complexes and process for preparing alcoholic compounds using these
06/27/2003CA2415185A1 Process for preparing heterocyclic (r)- and (s)-cyanohydrins
06/26/2003WO2003052572A2 System and method for displaying editorial content through television navigation controls and electronic program guides
06/26/2003WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
06/26/2003WO2003051846A2 Substituted phenyl derivatives
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051801A2 Synthesis of alpha, beta, beta-trifluorostyrene via in-situ formation of trifluorovinyl metal halide
06/26/2003WO2003051276A2 Therapeutic heterocycles
06/26/2003WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
06/26/2003US20030120085 Novel benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides
06/26/2003US20030120073 Such as d-4-hydroxyphenylglycine methyl ester for treatment of autoimmune diseases, glucose intolerance, diabetes, obesity, cancer, and psoriasis; drug screening
06/26/2003US20030119936 Making by photopolymerization of a reactive mesogen having a photopolymerizable endgroup, such as a diene; intermediate 2,7-bis(5-(4-hydroxyphenyl)thien-2-yl)-9,9-dipropylfluorene
06/26/2003US20030119914 Bis(thio-hydrazide amide) compounds; anticancer agents
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030118924 Radiation transparent substrate; optical recording media
06/26/2003CA2471424A1 Synthesis of alpha, beta, beta-trifluorostyrene via in-situ formation of trifluorovinyl metal halide
06/26/2003CA2470276A1 Substituted phenyl derivatives
06/26/2003CA2468978A1 Therapeutic heterocycles
06/26/2003CA2468657A1 System and method for displaying editorial content through television navigation controls and electronic program guides
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321483A1 3,4-alkylenedioxythiophene compounds and polymers thereof
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1025086B1 Benzamidine derivatives as factor xa inhibitors
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents